Assessment of lipid peroxidation and serum vitamin E concentration in dogs with immune-mediated hemolytic anemia

American Journal of Veterinary Research

Volumn 65, Issue 12, 2004, Pages 1621-1624

  Pesillo, S Anna ^a,b   Freeman, Lisa M ^a   Rush, John E ^a  

^a TUFTS UNIVERSITY   (United States)

^b Angell Memorial Animal Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; DELTA TOCOPHEROL; GAMMA TOCOPHEROL; LIPID; MALONALDEHYDE;

ANTIOXIDANT ACTIVITY; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD SAMPLING; COLORIMETRY; CONTROLLED STUDY; DOG; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; VITAMIN BLOOD LEVEL;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORIMETRY; DOG DISEASES; DOGS; FEMALE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; TOCOPHEROLS; VITAMIN E;

CANIS FAMILIARIS;

EID: 11144350966     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.1621     Document Type: Article

References (16)

1. Jackson ML, Kruth SA. Immune-mediated hemolytic anemia and thrombocytopenia in the dog: a retrospective study of 55 cases diagnosed from 1969 through 1983 at the Western College of Veterinary Medicine. Can Vet J 1985;26:245-250.
2. Klag AR, Giger U, Shofer FS. Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990). J Am Vet Med Assoc 1993;202:783-788.
3. Reimer ME, Troy GC, Warnick LD. Immune-mediated hemolytic anemia: 70 cases (1988-1996). J Am Anim Hosp Assoc 1999; 35:384-391.
4. Burgess K, Moore A, Rand W, et al. Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide. J Vet Intern Med 2000;14:456-462.
5. Scott-Moncrieff JC, Treadwell NG, McCullough SM, et al. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 2001;37:220-227.
6. Grundy SA, Barton C. Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999). J Am Vet Med Assoc 2001;218:543-546.
7. Carr AP, Panciera DL, Kidd L. Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs. J Vet Intern Med 2002; 16:504-509.
8. Mason N, Duval D, Shofer FS, et al. Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: a randomized controlled clinical trial. J Vet Intern Med 2003;17:206-212.
9. Harvey JW. Erythrocyte metabolism. In: Kaneko J, ed. Clinical biochemistry of domestic animals. 4th ed. San Diego: Academic Press Inc, 1989;185-234.
10. Tatum VL, Chow CK. Antioxidant status and susceptibility of sickle erythrocytes to oxidative and osmotic stress. Free Radic Res 1996; 25:133-139.
11. De Franceschi L, Fattovich G, Turrini F, et al. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology 2000; 31:997-1004.
12. Cighetti G, Duca L, Bortone L, et al. Oxidative status and malondialdehyde in β-thalassaemia patients. Eur J Clin Invest 2002; 32(suppl 1):55-60.
13. Ivanov IT. Low pH-induced hemolysis of erythrocytes is related to the entry of the acid into cytosole and oxidative stress on cellular membranes. Biochim Biophys Acta 1999; 1415:349-360.
14. Cruz Silva MM, Madeira VM, Almeida LM, et al. Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure. Biochim Biophys Acta 2000; 1464:49-61.
15. Freeman LM, Brown DJ, Rush JE. Assessment of degree of oxidative stress and antioxidant concentrations in dogs with idiopathic dilated cardiomyopathy. J Am Vet Med Assoc 1999; 215:644-646.
16. Traber MG. Vitamin E. In: Shils ME, Olson JA, Shike M, et al, eds. Modern nutrition in health and disease. 9th ed. Baltimore: The Williams & Wilkins Co, 1999;347-362.